Cargando…
Disease progression and brain atrophy in NMDAR encephalitis: Associated factor & clinical implication
OBJECTIVE: We investigated the longitudinal pattern, determining factors, and clinical implications of brain volume changes in N‐methyl d‐aspartate receptor‐antibody (NMDAR) encephalitis. METHODS: Baseline clinical profiles, treatment profiles, and outcome measured using the Clinical Assessment Scal...
Autores principales: | Lee, Woo‐Jin, Lee, Soon‐Tae, Kim, Do‐Yong, Kim, Soyun, Chu, Kon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268893/ https://www.ncbi.nlm.nih.gov/pubmed/35715951 http://dx.doi.org/10.1002/acn3.51604 |
Ejemplares similares
-
Prodromal headache in anti‐NMDAR encephalitis: An epiphenomenon of NMDAR autoimmunity
por: Tominaga, Naomi, et al.
Publicado: (2018) -
Bortezomib treatment for severe refractory anti‐NMDA receptor encephalitis
por: Shin, Yong‐Won, et al.
Publicado: (2018) -
Molecular Pathogenesis of Anti-NMDAR Encephalitis
por: Ding, Hao, et al.
Publicado: (2015) -
The Chinese experience with anti-NMDAR encephalitis
por: Desestret, Virginie
Publicado: (2020) -
Psychiatric manifestations of anti-NMDAR encephalitis
por: Martins, D., et al.
Publicado: (2021)